Effective treatment for multiple sclerosis could be available within five years
5 August 2020
In what is being called the ‘holy grail’ of multiple sclerosis (MS) therapy, researchers from 15 institutions including Professor Kenneth Smith (Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Queen Square Institute of Neurology) found an existing diabetes drug could be used to treat MS patients.